|

Personalized Treatment of Urogenital Cancers Depends on the Microbiome

RECRUITINGN/ASponsored by Zealand University Hospital
Actively Recruiting
PhaseN/A
SponsorZealand University Hospital
Started2020-05-01
Est. completion2025-05-01
Eligibility
Age40 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03962920

Summary

This is a randomized controlled trial where patients undergoing surgical treatment for urogenital cancers will be randomized in a two arms study: surgical treatment + antibiotics OR surgical treatment + placebo.

Eligibility

Age: 40 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* Biopsy verified diagnosis of urological cancer, localized disease

Exclusion Criteria:

* Hospitalization within three months of surgery
* Antibiotics within three months of surgery
* Infectious disease, including UTI's within three months of surgery
* History of cancers of the genitourinary tract
* Diabetes

Conditions2

CancerMicrobial Disease

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.